Charles S Berenson

Summary

Affiliation: University at Buffalo
Country: USA

Publications

  1. pmc Mammalian cell ganglioside-binding specificities of E. coli enterotoxins LT-IIb and variant LT-IIb(T13I)
    Charles S Berenson
    Infectious Disease Division, Department of Veterans Affairs Western New York Healthcare System, State University of New York at Buffalo School of Medicine, Buffalo, NY 14215, USA
    Glycobiology 20:41-54. 2010
  2. pmc Ganglioside-binding specificities of E. coli enterotoxin LT-IIc: Importance of long-chain fatty acyl ceramide
    Charles S Berenson
    Division of Infectious Disease 151, Department of Veterans Affairs Western New York Healthcare System, State University of New York at Buffalo School of Medicine, 3495 Bailey Avenue, Buffalo, NY 14215, USA
    Glycobiology 23:23-31. 2013
  3. pmc Binding to gangliosides containing N-acetylneuraminic acid is sufficient to mediate the immunomodulatory properties of the nontoxic mucosal adjuvant LT-IIb(T13I)
    Hesham F Nawar
    Witebsky Center for Microbial Pathogenesis and Immunology and Department of Microbiology and Immunology, University at Buffalo, State University of New York at Buffalo, Buffalo, New York 14214, USA
    Clin Vaccine Immunol 17:969-78. 2010
  4. pmc Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung disease
    Charles S Berenson
    Infectious Disease Division, Department of Veterans Affairs Western New York Healthcare System, State University of New York at Buffalo School of Medicine, Buffalo, NY 14215, USA
    Am J Respir Crit Care Med 174:31-40. 2006
  5. ncbi request reprint Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease
    Charles S Berenson
    Division of Infectious Diseases, Department of Veterans Affairs Western New York Healthcare System, State University of New York at Buffalo School of Medicine, Buffalo, NY 14215, USA
    J Infect Dis 194:1375-84. 2006
  6. pmc Phagocytic dysfunction of human alveolar macrophages and severity of chronic obstructive pulmonary disease
    Charles S Berenson
    Infectious Disease and Pulmonary Medicine Divisions, Department of Veterans Affairs Western New York Healthcare System, State University of New York at Buffalo School of Medicine
    J Infect Dis 208:2036-45. 2013
  7. ncbi request reprint Nontypeable Haemophilus influenzae-binding gangliosides of human respiratory (HEp-2) cells have a requisite lacto/neolacto core structure
    Charles S Berenson
    Infectious Disease Division, Department of Veterans Affairs Western New York Healthcare System, State University of New York at Buffalo School of Medicine, Buffalo, New York 14215, USA
    FEMS Immunol Med Microbiol 45:171-82. 2005
  8. ncbi request reprint Effect of tenofovir disoproxil fumarate on the pharmacokinetics and pharmacodynamics of total, R-, and S-methadone
    Patrick F Smith
    University at Buffalo School of Pharmacy and Pharmaceutical Sciences, New York 14260, USA
    Pharmacotherapy 24:970-7. 2004
  9. pmc Outer membrane protein P6 of nontypeable Haemophilus influenzae is a potent and selective inducer of human macrophage proinflammatory cytokines
    Charles S Berenson
    Division of Infectious Diseases 151, VA Western NY Healthcare System, 3495 Bailey Avenue, Buffalo, New York 14215, USA
    Infect Immun 73:2728-35. 2005
  10. ncbi request reprint Inhibition of atazanavir oral absorption by lansoprazole gastric acid suppression in healthy volunteers
    Desiree L Tomilo
    School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, New York 14260, USA
    Pharmacotherapy 26:341-6. 2006

Collaborators

Detail Information

Publications13

  1. pmc Mammalian cell ganglioside-binding specificities of E. coli enterotoxins LT-IIb and variant LT-IIb(T13I)
    Charles S Berenson
    Infectious Disease Division, Department of Veterans Affairs Western New York Healthcare System, State University of New York at Buffalo School of Medicine, Buffalo, NY 14215, USA
    Glycobiology 20:41-54. 2010
    ..These studies underscore the high degree of specificity required for ganglioside-protein interactions...
  2. pmc Ganglioside-binding specificities of E. coli enterotoxin LT-IIc: Importance of long-chain fatty acyl ceramide
    Charles S Berenson
    Division of Infectious Disease 151, Department of Veterans Affairs Western New York Healthcare System, State University of New York at Buffalo School of Medicine, 3495 Bailey Avenue, Buffalo, NY 14215, USA
    Glycobiology 23:23-31. 2013
    ..These studies are the first demonstration of LT-ganglioside dependence upon ceramide composition and underscore the contribution of long-chain fatty acyl ceramides to host cell interactions...
  3. pmc Binding to gangliosides containing N-acetylneuraminic acid is sufficient to mediate the immunomodulatory properties of the nontoxic mucosal adjuvant LT-IIb(T13I)
    Hesham F Nawar
    Witebsky Center for Microbial Pathogenesis and Immunology and Department of Microbiology and Immunology, University at Buffalo, State University of New York at Buffalo, Buffalo, New York 14214, USA
    Clin Vaccine Immunol 17:969-78. 2010
    ..The nontoxic mutant enterotoxin LT-IIb(T13I), therefore, is potentially a new and safe human mucosal adjuvant...
  4. pmc Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung disease
    Charles S Berenson
    Infectious Disease Division, Department of Veterans Affairs Western New York Healthcare System, State University of New York at Buffalo School of Medicine, Buffalo, NY 14215, USA
    Am J Respir Crit Care Med 174:31-40. 2006
    ..Outer membrane protein (OMP) P6 and lipooligosaccharide (LOS) of NTHI are potent immunomodulators. We theorized that alveolar macrophages in COPD possess fundamental immune defects that permit NTHI to evade host responses...
  5. ncbi request reprint Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease
    Charles S Berenson
    Division of Infectious Diseases, Department of Veterans Affairs Western New York Healthcare System, State University of New York at Buffalo School of Medicine, Buffalo, NY 14215, USA
    J Infect Dis 194:1375-84. 2006
    ..However, the immunologic mechanisms that mediate NTHI-induced macrophage responses are poorly understood. We hypothesized that immunologic responses of alveolar macrophages to NTHI are impaired in COPD...
  6. pmc Phagocytic dysfunction of human alveolar macrophages and severity of chronic obstructive pulmonary disease
    Charles S Berenson
    Infectious Disease and Pulmonary Medicine Divisions, Department of Veterans Affairs Western New York Healthcare System, State University of New York at Buffalo School of Medicine
    J Infect Dis 208:2036-45. 2013
    ....
  7. ncbi request reprint Nontypeable Haemophilus influenzae-binding gangliosides of human respiratory (HEp-2) cells have a requisite lacto/neolacto core structure
    Charles S Berenson
    Infectious Disease Division, Department of Veterans Affairs Western New York Healthcare System, State University of New York at Buffalo School of Medicine, Buffalo, New York 14215, USA
    FEMS Immunol Med Microbiol 45:171-82. 2005
    ..Collectively, our studies denote NTHI-binding gangliosides as lacto/neolacto series structures...
  8. ncbi request reprint Effect of tenofovir disoproxil fumarate on the pharmacokinetics and pharmacodynamics of total, R-, and S-methadone
    Patrick F Smith
    University at Buffalo School of Pharmacy and Pharmaceutical Sciences, New York 14260, USA
    Pharmacotherapy 24:970-7. 2004
    ..To evaluate the potential effect of tenofovir disoproxil fumarate (DF) on the pharmacokinetics of methadone...
  9. pmc Outer membrane protein P6 of nontypeable Haemophilus influenzae is a potent and selective inducer of human macrophage proinflammatory cytokines
    Charles S Berenson
    Division of Infectious Diseases 151, VA Western NY Healthcare System, 3495 Bailey Avenue, Buffalo, New York 14215, USA
    Infect Immun 73:2728-35. 2005
    ..OMP P6 of NTHI is a specific trigger of bacteria-induced human macrophage inflammatory events, with IL-8 and TNF-alpha as key effectors of P6-induced macrophage responses...
  10. ncbi request reprint Inhibition of atazanavir oral absorption by lansoprazole gastric acid suppression in healthy volunteers
    Desiree L Tomilo
    School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, New York 14260, USA
    Pharmacotherapy 26:341-6. 2006
    ..To determine whether the pharmacokinetics of atazanavir, a protease inhibitor used to treat human immunodeficiency virus (HIV) infection, are altered by its coadministration with lansoprazole, a proton pump inhibitor...
  11. pmc Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease
    Sanjay Sethi
    Division of Pulmonary Critical Care and Sleep Medicine, and Division of Infectious Diseases, Department of Medicine, University at Buffalo, Buffalo, NY, USA
    Am J Respir Crit Care Med 173:991-8. 2006
    ..Objective: To test the hypothesis that bacterial colonization is associated with airway inflammation in stable COPD...
  12. ncbi request reprint The role of ceramide of human macrophage gangliosides in activation of human macrophages
    Charles S Berenson
    Infectious Diseases Section, Department of Veterans Affairs Western New York Healthcare System, State University of New York at Buffalo, School of Medicine, 14215, USA
    J Leukoc Biol 72:492-502. 2002
    ..This study underscores the importance of structurally distinct ceramide of macrophage gangliosides as a critical domain for ganglioside-mediated activation of human macrophages...
  13. ncbi request reprint The influence of St. John's wort on the pharmacokinetics and protein binding of imatinib mesylate
    Patrick Smith
    School of Pharmacy and Pharmaceutical Sciences, University of Buffalo, Buffalo, New York, USA
    Pharmacotherapy 24:1508-14. 2004
    ..To determine the effect of St. John's wort on the pharmacokinetics of imatinib mesylate...